Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563). [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of intravenously administered benralizumab (MEDI-563) in asthma has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2020-10-12